☆ 4.8 Article

Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality

ELIFE (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Editorial Material Medicine, General & Internal

Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel

Alice K. Pau et al.

ANNALS OF INTERNAL MEDICINE (2021)

添加到收藏夹

Article Pathology

Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG

Eric Salazar et al.

Summary: Convalescent plasma therapy containing high-titer anti-spike protein RBD IgG has shown to significantly reduce mortality in hospitalized COVID-19 patients when transfused within 44 hours, confirming previous findings and showing promise in the treatment of the disease.

AMERICAN JOURNAL OF PATHOLOGY (2021)

添加到收藏夹

Article Immunology

COVID-19 convalescent plasma composition and immunological effects in severe patients

Yeny Acosta-Ampudia et al.

Summary: Convalescent plasma treatment for severe COVID-19 patients showed improvement in immune response and metabolic status, suggesting promising therapeutic implications for further studies.

JOURNAL OF AUTOIMMUNITY (2021)

添加到收藏夹

Letter Health Care Sciences & Services

Place of Death and End-of-Life Care Utilization among COVID-19 Decedents in a Massachusetts Health Care System

Isaac S. Chua et al.

JOURNAL OF PALLIATIVE MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

R. Libster et al.

Summary: A randomized, double-blind, placebo-controlled trial of convalescent plasma with high IgG titers against SARS-CoV-2 in older adult patients within 72 hours after the onset of mild Covid-19 symptoms found that early administration of high-titer convalescent plasma reduced the progression of Covid-19 in mildly ill infected older adults.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

M. J. Joyner et al.

Summary: This study found that higher anti-SARS-CoV-2 IgG antibody levels in convalescent plasma were associated with a lower risk of death among patients hospitalized with Covid-19 who were not receiving mechanical ventilation. The association between antibody levels and mortality risk was moderated by mechanical ventilation status, with no significant effect seen in patients who had already received ventilation.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

V. A. Simonovich et al.

Summary: There were no significant differences observed in clinical status or overall mortality between patients treated with convalescent plasma and those who received placebo in the treatment of severe Covid-19 pneumonia. The study results indicate that both groups had similar clinical outcomes and mortality rates after 30 days.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021

Summer E. Galloway et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

添加到收藏夹

Review Medicine, General & Internal

Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19 A Systematic Review and Meta-analysis

Perrine Janiaud et al.

Summary: Convalescent plasma treatment showed no significant decrease in all-cause mortality or benefit for other clinical outcomes compared to placebo or standard of care. The certainty of the evidence ranged from low to moderate for all-cause mortality and remained low for other outcomes.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Review Hematology

COVID-19 convalescent plasma: Interim recommendations from the AABB

Claudia S. Cohn et al.

TRANSFUSION (2021)

添加到收藏夹

Article Immunology

Vaccine hesitancy and anti-vaccination in the time of COVID-19: A Google Trends analysis

Samuel Pullan et al.

Summary: The COVID-19 pandemic has led to increased calls for a vaccine, but concerns about vaccine hesitancy and anti-vaccine sentiments may hinder vaccine uptake. Reasons for vaccine hesitancy commonly include concerns about mercury content, autism association, and perceived vaccine dangers. Despite the increasing demand for a coronavirus vaccine, searches for anti-vaccine information have also continued to grow during the pandemic.

VACCINE (2021)

添加到收藏夹

Review Microbiology

The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19

Arturo Casadevall et al.

Summary: Antibody therapies like convalescent plasma and monoclonal antibodies have emerged as potential treatments for COVID-19, following the principles of specificity, temporality, and quantity in administering specific antibodies early in the disease course. Historical lessons suggest that antibody therapy is most effective when used early in respiratory diseases.

MBIO (2021)

添加到收藏夹

Article Medicine, General & Internal

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

Robert Challen et al.

Summary: The study found that the mortality hazard ratio associated with infection with VOC-202012/1 compared with previously circulating variants was 1.64, indicating an increase in deaths from 2.5 to 4.1 per 1000 detected cases in comparatively low risk group of covid-19 patients in the community. This suggests that infection with VOC-202012/1 may lead to substantial additional mortality compared with previously circulating variants, impacting healthcare capacity planning and control policies.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Article Immunology

Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment

Jian Wu et al.

Summary: IL-6 levels are closely linked to various indicators and prognosis in COVID-19 patients, serving as a stable marker for inflammation. Treatments like tocilizumab and convalescent plasma therapy can reduce IL-6 levels, alleviate inflammation, and are particularly effective for critically ill patients.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Critical Care Medicine

Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Double-Blind Randomized Trial*

Elliott Bennett-Guerrero et al.

Summary: This study found that administration of convalescent plasma to hospitalized patients with coronavirus disease 2019 infection did not improve outcomes, despite convalescent plasma having high neutralizing activity and increasing antibodies to severe acute respiratory syndrome coronavirus 2.

CRITICAL CARE MEDICINE (2021)

添加到收藏夹

Article Immunology

Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19

Purbita Bandopadhyay et al.

Summary: This study found that convalescent plasma therapy (CPT) has an anti-inflammatory role in COVID-19 patients beyond the presence of neutralizing antibodies. CPT can significantly reduce circulating interleukin-6 and interferon-gamma-inducible protein 10, leading to rapid alleviation of hypoxia.

JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Medicine, General & Internal

Trends in COVID-19 Risk-Adjusted Mortality Rates

Leora Horwitz et al.

Summary: A study in a three-hospital academic health system in New York showed a decrease in hospital mortality rates among COVID-19 patients, with adjusted mortality dropping from 25.6% in March to 7.6% in August. The standardized mortality ratio also decreased from 1.26 in March to 0.38 in August, indicating an improving trend in patient outcomes. These findings suggest that mortality from COVID-19 may be decreasing even after adjusting for patient characteristics.

JOURNAL OF HOSPITAL MEDICINE (2021)

添加到收藏夹

Article Pathology

Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality

Eric Salazar et al.

AMERICAN JOURNAL OF PATHOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment

Jing Sun et al.

CELL (2020)

添加到收藏夹

Article Medicine, General & Internal

Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial

Ling Li et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Early safety indicators of COVID-19 convalescent plasma in 5000 patients

Michael J. Joyner et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

添加到收藏夹

Letter Geriatrics & Gerontology

Distribution in Place of Death for COVID-19-Related Mortality in the United States

Sarah Chuzi et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2020)

添加到收藏夹

Article Medicine, General & Internal

Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients

Michael J. Joyner et al.

MAYO CLINIC PROCEEDINGS (2020)

添加到收藏夹

Review Microbiology

Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework

Liise-anne Pirofski et al.

MBIO (2020)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Convalescent plasma falls flat in first randomized trial

Cormac Sheridan

NATURE BIOTECHNOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study

Sean T. H. Liu et al.

NATURE MEDICINE (2020)

添加到收藏夹

Editorial Material Medicine, General & Internal

The FDA and the Importance of Trust

Lindsey R. Baden et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Editorial Material Medicine, General & Internal

Convalescent plasma is ineffective for covid-19 Lessons from the Placid Trial

Elizabeth B. Pathak

BMJ-BRITISH MEDICAL JOURNAL (2020)

添加到收藏夹

Article Medicine, General & Internal

Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)

Anup Agarwal et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

添加到收藏夹

Article Environmental Sciences

Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients

Christel Faes et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

添加到收藏夹

Article Oncology

Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer Patients

Douglas Tremblay et al.

CANCER MEDICINE (2020)

添加到收藏夹

Review Medicine, General & Internal

Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis

Min Seo Kim et al.

PLOS MEDICINE (2020)

添加到收藏夹

Review Medicine, Research & Experimental

The Assessment of Convalescent Plasma Efficacy against COVID-19

Arturo Casadevall et al.

MED (2020)

添加到收藏夹

Article Medicine, General & Internal

Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma

Yasmin Maor et al.

ECLINICALMEDICINE (2020)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.